Cyclic melanocortin analog
Melanotan II
2 sizes · 2 mg–5 mg
From$29.95Indicative
- Availability
- In stock
- Documentation
- COA issued per lot
Melanocortin Analogs
Melanotan I
NLR-3503
Melanocortin analog
From$29.95IndicativeIn stockCOA issued per lot
Adding to the cart does not place an order. Checkout produces an order request that is reviewed against buyer qualification before anything is accepted or charged.
Reference configuration. Pack sizes are pending supplier confirmation.
Overview
The alias maps to an active approved only as a particular implant product. A powder listing is not that product and does not inherit its approval.
Northlake issues the documentation set against the released lot. Where a specification below reads as pending, no verified value has been supplied, and none has been invented to fill the gap.
Specifications
Every row states where its value came from. Values still pending supplier verification are shown muted and are excluded from this page’s structured data, so nothing unverified is published to search engines either.
| Catalog number | NLR-3503 |
|---|---|
| Canonical identity | AfamelanotidePending verificationIdentity is inferred from the listing label and has not been confirmed against a supplier document. |
| Material type | Synthetic melanocortin analog; approved only as a specific implant drug product |
| Physical form | Lyophilized powderPlaceholder |
| Purity | Pending — method and acceptance criteria not yet suppliedPending verification |
| Sequence | Pending — full sequence required from the supplier recordPending verification |
| Molecular formula | C78H111N21O19Pending verificationParent-compound value. The shipped salt, counterion, hydrate state, and assay basis are pending on the supplier record.Source: PubChem CID 16197727 — parent compound |
| Molecular weight | 1646.8 g/molPending verificationParent-compound value. The shipped salt, counterion, hydrate state, and assay basis are pending on the supplier record.Source: PubChem CID 16197727 — parent compound |
| CAS number | Pending — CAS not confirmed for the supplied formPending verification |
| Solubility | Pending — solubility data required from the supplier recordPending verification |
How to read these specifications
- VerifiedChecked against a primary source — a released lot report or a supplier specification — and safe to quote.
- Pending verificationA real value exists but has not been confirmed for this record yet.
- PlaceholderIllustrative sample data. Not a measurement, not a specification, and not published to search engines as either.
Documentation
Certificates of analysis are issued per lot, so the certificate you receive describes the material you receive rather than a representative batch. Safety data sheets and specification sheets are product-level.
| Document | Lot | Access |
|---|---|---|
| Safety data sheet | — | Request document |
| Product specification | — | Request document |
No lot-matched certificate is published for this record yet, which is why none is listed above. Lot lookup is at /coa.
Handling and storage
Storage conditions are taken from the approved supplier specification or the safety data sheet. They are never estimated, which is why they read as pending until that document is on file.
| Storage | Pending — storage is taken from the approved supplier specification or SDS, never estimatedPending verification |
|---|---|
| Laboratory handling | Laboratory material. Handle with appropriate personal protective equipment and consult the safety data sheet before first use.Placeholder |
| Catalog line | Research Reagents |
| Category | Melanocortin Analogs |
| Last reviewed | Jul 31, 2026 |
Buyer eligibility
Not released for supply
Held pending regulatory verification. Published as a reference entry only.
For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, and not for food or cosmetic use.
Orders from this line ship to qualified institutional or business accounts only. Account qualification is reviewed before an order is accepted.
Outstanding before this record can be sold
- Supplier legal name and site of manufacture
- Full sequence or structure, including salt and counterion
- Lot-matched certificate of analysis
- Identity method and purity method with acceptance criteria
- Residual solvents
- Counsel decision, payment processor approval, and insurer approval
HOLD — approved-drug active / alias ambiguity
